Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab0Recruiting1
DB13062ME-3440Recruiting1
DB05136Bavituximab1Completed1
DB08871Eribulin1Recruiting1
DB11793Niraparib1Recruiting1
DB01229Paclitaxel1Completed1
DB01229Paclitaxel1Recruiting1
DB13005Rebastinib1Recruiting1
DB00515Cisplatin1 / 2Terminated1
DB01590Everolimus1 / 2Recruiting1
DB00990Exemestane1 / 2Recruiting1
DB09073Palbociclib1 / 2Recruiting1
DB01217Anastrozole2Recruiting1
DB01217Anastrozole2Terminated1
DB00112Bevacizumab2Recruiting1
DB00531Cyclophosphamide2Completed1
DB00531Cyclophosphamide2Recruiting1
DB00997Doxorubicin2Completed1
DB00997Doxorubicin2Recruiting1
DB08871Eribulin2Recruiting2
DB00990Exemestane2Recruiting1
DB00947Fulvestrant2Recruiting1
DB01006Letrozole2Recruiting1
DB00331Metformin2Completed1
DB09073Palbociclib2Recruiting2
DB06589Pazopanib2Terminated1
DB00675Tamoxifen2Recruiting1
DB00072Trastuzumab2Completed1
DB00997Doxorubicin3Active Not Recruiting1
DB01590Everolimus3Recruiting1
DB00990Exemestane3Recruiting1
DB00947Fulvestrant3Recruiting1
DB11793Niraparib3Active Not Recruiting1
DB09073PalbociclibNot AvailableCompleted1